- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Tyrosine kinase signaling-independent MET-targeting with CAR-T cells ; volume:21 ; number:1 ; day:1 ; month:10 ; year:2023 ; pages:1-17 ; date:12.2023
Journal of translational medicine ; 21, Heft 1 (1.10.2023), 1-17, 12.2023
- Urheber
-
Qin, Anna
Qin, Yuan
Lee, Joseph
Musket, Anna
Ying, Mingyao
Krenciute, Giedre
Marincola, Francesco M.
Yao, Zhi Q.
Musich, Phillip R.
Xie, Qian
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-023-04521-9
- URN
-
urn:nbn:de:101:1-2024020112412440380375
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Qin, Anna
- Qin, Yuan
- Lee, Joseph
- Musket, Anna
- Ying, Mingyao
- Krenciute, Giedre
- Marincola, Francesco M.
- Yao, Zhi Q.
- Musich, Phillip R.
- Xie, Qian
- SpringerLink (Online service)
Ähnliche Objekte (12)
Engineering CAR-T cells
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturing
Strategies to enhance CAR-T persistence
Gut microbiome and CAR-T therapy
Target selection for CAR-T therapy
Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma
Recent advances in CAR-T cell engineering
CAR-T Cell Therapy for Solid Tumors
New development in CAR-T cell therapy
Dynamic fine-tuning of CAR-T cell therapy
Engineering CAR-T cells
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturing
Strategies to enhance CAR-T persistence
Gut microbiome and CAR-T therapy
Target selection for CAR-T therapy
Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma
Recent advances in CAR-T cell engineering
CAR-T Cell Therapy for Solid Tumors
New development in CAR-T cell therapy
Dynamic fine-tuning of CAR-T cell therapy
Engineering CAR-T cells
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study
Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturing
Strategies to enhance CAR-T persistence
Gut microbiome and CAR-T therapy
Target selection for CAR-T therapy
Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma
Recent advances in CAR-T cell engineering
CAR-T Cell Therapy for Solid Tumors
New development in CAR-T cell therapy